• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Model Number HYLAN G-F 20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Pain (1994); Swelling/ Edema (4577)
Event Date 05/14/2013
Event Type  Injury  
Event Description
A (b)(6) male with pmh significant for osteoarthritis received hylan g-f (synvisc) 48mg/6ml injection in both knees on (b)(6) 2013.Patient contacted primary care clinic (b)(6) 2013 with complaints of right knee pain and swelling post injection.Patient was seen by rheumatologist who performed injections and right knee arthrocentesis completed.12cc of fluid removed from right knee.Patient instructed to continue naproxen for pain/ inflammation and return to clinic 3 days later for f/u.Patient reported to ed over the weekend, (b)(6) 2013, with recurrent swelling and pain.Arthrocentesis completed in ed produced-100cc of fluid.Patient was sent home from ed with prn oxycodone/apap.F/u with rheumatologist (b)(6) 2013, showed continued swelling of knee joint.Naproxen stopped and etodolac started.F/u with rheumatologist (b)(6) 2013 states improvement in knee swelling but continued knee pain despite trail of multiple nsaids.Patient was referred to orthopedics for further treatments options.Scheduled for ortho f/u (b)(6) 2013.Symptoms: pseudoseptic reactions; suspect during # 1 dosing: inject the contents of one syringe (48 mg) intra - articularly once for procedure to affected knee(s) to reduce pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key10811035
MDR Text Key215609922
Report NumberMW5097715
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 08/02/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberHYLAN G-F 20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/06/2020
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age53 YR
Patient Weight40
-
-